Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23038685 | 0.98 | DNM1 (0.47) | DNM1USP2HTTLPAR1LPAR3 | |
| SCHEMBL891413 | 0.98 | DNM1 (0.47) | DNM1USP2HTTLPAR1LPAR3 | |
| SCHEMBL6379210 | 0.98 | DNM1 (0.47) | DNM1USP2HTTLPAR1LPAR3 | |
| SCHEMBL1607078 | 0.98 | DNM1 (0.47) | DNM1USP2HTTLPAR1LPAR3 | |
| SCHEMBL253114 | 0.93 | TSHR (0.37) | DNM1USP2HTTALDH1A1CNR1 | |
| SCHEMBL7194803 | 0.91 | DNM1 (0.43) | DNM1USP2HTTALDH1A1CNR1 | |
| Ammonia Solution, Strong SCHEMBL28151442 | 0.91 | TSHR (0.36) | DNM1USP2HTTALDH1A1CNR1 | |
| SCHEMBL27928001 | 0.91 | TSHR (0.36) | DNM1USP2HTTALDH1A1CNR1 | |
| SCHEMBL23038764 | 0.91 | DNM1 (0.43) | DNM1USP2HTTALDH1A1CNR1 | |
| SCHEMBL27607732 | 0.91 | TSHR (0.36) | DNM1USP2HTTALDH1A1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10020406-B2 | Protective film for solar cell and solar cell comprising the same | LG CHEM, LTD. (KR) | 2018-07-10 | — | — | US | claimed |
| EP-2711179-B1 | PROTECTION FILM FOR SOLAR CELL APPLICATION AND SOLAR CELL HAVING SAME | LG CHEMICAL LTD (KR) | 2018-07-04 | — | — | EP | claimed |
| EP-2711179-A2 | PROTECTION FILM FOR SOLAR CELL APPLICATION AND SOLAR CELL HAVING SAME | LG Chem, Ltd. (KR) | 2014-03-26 | — | — | EP | claimed |
| US-20140069497-A1 | PROTECTIVE FILM FOR SOLAR CELL AND SOLAR CELL COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-03-13 | — | — | US | claimed |
| US-20260015540-A1 | EMULSIFIER COMPOSITIONS, AND RELATED METHODS AND WELLBORE FLUIDS INCLUDING THE EMULSIFIER COMPOSITIONS | SCHLUMBERGER TECHNOLOGY CORP (US) | 2026-01-15 | — | — | US | disclosed |
| US-12034122-B2 | Electrolytic solution for lithium-ion secondary battery and lithium-ion secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-112074983-B | Electrolyte for lithium ion secondary battery and lithium ion secondary battery | 株式会社村田制作所 | 2024-06-04 | — | — | CN | disclosed |
| CN-113912653-B | Method for improving bulk density of beta-nicotinamide mononucleotide crystalline powder | 天津大学 | 2024-04-23 | — | — | CN | disclosed |
| EP-3806220-A1 | ELECTROLYTE FOR LITHIUM-ION SECONDARY CELL, AND LITHIUM-ION SECONDARY CELL | Murata Manufacturing Co., Ltd. (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20210066756-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY AND LITHIUM-ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| CN-112074983-A | Electrolyte for lithium ion secondary battery and lithium ion secondary battery | 株式会社村田制作所 | 2020-12-11 | — | — | CN | disclosed |
| US-10020406-B2 | Protective film for solar cell and solar cell comprising the same | LG CHEM, LTD. (KR) | 2018-07-10 | — | — | US | disclosed |
| EP-2711179-A2 | PROTECTION FILM FOR SOLAR CELL APPLICATION AND SOLAR CELL HAVING SAME | LG Chem, Ltd. (KR) | 2014-03-26 | — | — | EP | disclosed |
| US-20140069497-A1 | PROTECTIVE FILM FOR SOLAR CELL AND SOLAR CELL COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2014-03-13 | — | — | US | disclosed |
| WO-2013178560-A1 | METHOD FOR THE PRODUCTION OF SOLID ACCELERATORS FOR CONSTRUCTION MATERIAL MIXTURES | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-12-05 | — | — | WO | disclosed |
| WO-2013132507-A1 | AN INTEGRATED PROCESS FOR THE RECOVERY OF METAL CATALYSTS DURING THE MANUFACTURE OF PURIFIED TEREPHTHALIC ACID | RELIANCE INDUSTRIES LTD., (IN) | 2013-09-12 | — | — | WO | disclosed |
| EP-1054993-A1 | PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY | Lek Pharmaceutical and Chemical Co. D.D. (SI) | 2000-11-29 | — | — | EP | disclosed |
| EP-1042387-A1 | LAMINATING ADHESIVES HARDENABLE BY RADIATION | Henkel Kommanditgesellschaft auf Aktien (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999042601-A1 | PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY | LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D. (DE) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999033897-A1 | LAMINATING ADHESIVES HARDENABLE BY RADIATION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015540-A1 | EMULSIFIER COMPOSITIONS, AND RELATED METHODS AND WELLBORE FLUIDS INCLUDING THE EMULSIFIER COMPOSITIONS | AQP1, DEGS1, ADH1A | DNM1 269/4885USP2 2579/4885HTT 2002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.